New data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI™ SureScan™ pacing system experienced no complications related to the use of magnetic resonance imaging.
Medtronic
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
Medtronic Announces U.S. Trial Of Unique Therapy For Closure Of The Left Atrial Appendage
Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device as part of a U.S. clinical trial.
Medtronic Introduces The Vertex Select™ Reconstruction System Occipitocervical Module
Medtronic, Inc. announced the U.S. launch of the VERTEX SELECT™ Reconstruction System Occipitocervical Module.
FDA Approves New Medtronic Left Heart Lead for Cardiac Resynchronization Therapy Devices
Medtronic, Inc. today announced U.S. Food and Drug Administration approval and availability of the Attain Ability® left-heart lead (Model 4196) for use with cardiac resynchronization therapy devices for heart failure patients.
Medtronic Introduces The PEEK PREVAIL Device for Neck Surgery
Medtronic, Inc. today announced the U.S. launch of the PEEK PREVAIL™ Cervical Interbody Device.
Medtronic Completes Acquisition of CoreValve Inc.
In a move to further expand a comprehensive cardiovascular portfolio, Medtronic, Inc. announced today the completion of its acquisition of CoreValve Inc.
Medtronic Initiates Global Abdominal Aortic Aneurysm Study
Medtronic, Inc. today announced the start of ENGAGE¹, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic, Inc. today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
Medtronic’s Endeavor Stent Shows Consistent And Sustained Safety And Effectiveness Benefits At Two Years
New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc.
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Ardian, Inc., developer of a breakthrough catheter-based medical device to treat hypertension, announced today that Medtronic, Inc., one of the world’s leading medical technology companies, has led a $47 million financing of the company.
Medtronic Links Device for Heart to 13 Deaths
Medtronic said Friday that at least 13 people might have died in connection with a heart device that it recalled in 2007 but was still in widespread use.
Various Infuse Bone Graft Lawsuits Filed against Medtronic Inc.
Medtronic Inc. has recently been targeted in various lawsuits related to its Infuse Bone Graft, a medical device designed to stimulate bone growth.
Medtronic leads are under fire again as study cites failures
A newly published report in the Heart Rhythm Society (Washington) journal HeartRhythm shows that there could be a higher rate of failure for the Sprint Fidelis Leads, than previous studies have revealed.
Largest Study on Balloon Kyphoplasty Demonstrates Superior Benefits Compared to Non-Surgical Care in Treating Vertebral Compression Fractures
In the largest multicenter randomized controlled study of surgical intervention versus non-surgical care for acute vertebral compression fractures, patients undergoing balloon kyphoplasty showed superior improvement in quality of life, back function and back pain than those who were given non-surgical care.